Galapagos NV (GLPG)
29.33
+0.88
(+3.09%)
USD |
NASDAQ |
May 01, 16:00
29.33
0.00 (0.00%)
After-Hours: 20:00
Galapagos Max Drawdown (5Y): 89.62% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 89.62% |
March 31, 2024 | 88.37% |
February 29, 2024 | 88.37% |
January 31, 2024 | 88.37% |
December 31, 2023 | 88.37% |
November 30, 2023 | 88.37% |
October 31, 2023 | 88.37% |
September 30, 2023 | 87.53% |
August 31, 2023 | 86.68% |
July 31, 2023 | 86.68% |
June 30, 2023 | 86.68% |
May 31, 2023 | 86.68% |
April 30, 2023 | 86.68% |
March 31, 2023 | 86.68% |
February 28, 2023 | 86.34% |
January 31, 2023 | 86.34% |
December 31, 2022 | 86.34% |
November 30, 2022 | 85.72% |
October 31, 2022 | 84.86% |
September 30, 2022 | 84.57% |
August 31, 2022 | 82.84% |
July 31, 2022 | 82.84% |
June 30, 2022 | 82.84% |
May 31, 2022 | 82.84% |
April 30, 2022 | 82.84% |
Date | Value |
---|---|
March 31, 2022 | 82.84% |
February 28, 2022 | 82.84% |
January 31, 2022 | 82.84% |
December 31, 2021 | 82.84% |
November 30, 2021 | 82.40% |
October 31, 2021 | 81.95% |
September 30, 2021 | 80.96% |
August 31, 2021 | 79.94% |
July 31, 2021 | 79.12% |
June 30, 2021 | 74.87% |
May 31, 2021 | 73.66% |
April 30, 2021 | 72.21% |
March 31, 2021 | 72.21% |
February 28, 2021 | 69.86% |
January 31, 2021 | 64.66% |
December 31, 2020 | 64.66% |
November 30, 2020 | 58.21% |
October 31, 2020 | 57.49% |
September 30, 2020 | 55.31% |
August 31, 2020 | 52.42% |
July 31, 2020 | 47.82% |
June 30, 2020 | 47.82% |
May 31, 2020 | 47.82% |
April 30, 2020 | 47.82% |
March 31, 2020 | 47.82% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
40.67%
Minimum
Sep 2019
89.62%
Maximum
Apr 2024
71.56%
Average
82.17%
Median
Max Drawdown (5Y) Benchmarks
UCB SA | 50.06% |
Mithra Pharmaceuticals SA | -- |
Nyxoah SA | -- |
Celyad Oncology SA | -- |
MDxHealth SA | 100.0% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -29.48 |
Beta (5Y) | 0.2749 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 43.57% |
Historical Sharpe Ratio (5Y) | -0.6064 |
Historical Sortino (5Y) | -1.034 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.31% |